Paul J. Anderson

Interstitial high-dose-rate (HDR) brachytherapy for early stage prostate cancer: A report of 193 cases

Interstitial high-dose-rate (HDR) brachytherapy for early stage breast cancer

Interstitial high-dose-rate brachytherapy for early stage breast cancer: Median 5-year followup of 192 cases using multicatheter technique

Previous Transurethral Resection of the Prostate Is Not a Contraindication for Interstitial High-Dose-Rate Brachytherapy for Prostate Cancer

Interstitial high-dose-rate brachytherapy as monotherapy for early stage prostate cancer

Interstitial high-dose-rate (HDR) brachytherapy under local anesthesia for early stage prostate cancer

Interstitial High Dose Rate (HDR) Brachytherapy + IMRT vs. HDR Monotherapy for Early Stage Prostate Cancer

Hormonal blockade for salvage treatment of prostate-specific antigen only recurrent prostate cancer after interstitial high-dose-rate brachytherapy for early stage prostate cancer: long-term followup in 23 patients

High-dose-rate salvage treatment of prostate-specifc antigen only recurrent prostate cancer after radical prostatectomy: A feasibility study in 5 patients

Interstitial high-dose-rate brachytherapy + intensity modulated radiation therapy vs. high-dose-rate monotherapy for early stage prostate cancer: Median 7-year followup in 380 cases